HOME >> BIOLOGY >> NEWS
Smac-ing back at cancer cells

By mimicking a molecular switch that triggers cell death, researchers have killed cells grown in the laboratory from one of the most resilient and aggressive cancers a virulent brain cancer known as glioblastoma. The new approach to tricking the cell-death machinery could be applied to a wide range of cancers where this pathway, known as apoptosis, has been inactivated.

The researchers -- led by Xiaodong Wang, a Howard Hughes Medical Institute investigator at the University of Texas Southwestern Medical Center at Dallas and his colleagues Patrick Harran and Jef De Brabander -- published their findings in the September 3, 2004, issue of the journal Science.

Many cancer cells are particularly hardy because they have switched off the apoptotic machinery at one point or another, protecting them from the suicide process that their aberrant behavior would otherwise trigger.

To reactivate the cell-death pathway in cancer cells, the researchers sought to create a molecular mimic of a protein called Smac, which promotes apoptosis. Normally, when apoptosis is activated in cells that are damaged or no longer needed, Smac is released from the mitochondria, which are the cell's power plants. Once released, Smac binds to a group of gatekeeper proteins known as "inhibitor of apoptosis proteins" (IAPs), which normally hold in check the cell's chief executioner enzymes. These enzymes, called caspases, wreak lethal havoc in cells targeted for apoptosis. Smac's action is why it was named the "second mitochondria-derived activator of caspases."

Specifically, Wang and his colleagues sought to make a small molecule to mimic the function of the Smac protein, since a smaller molecule is better able to pass through the cell membrane to reach the cell's interior, where IAP-caspase resides.

"The idea for making this inhibitor molecule first arose in previous studies when our collaborator Dr. Yigong Shi solved the crystal structure of Smac interacting with
'"/>

Contact: Jennifer Michalowski
michalow@hhmi.org
301-215-8576
Howard Hughes Medical Institute
8-Sep-2004


Page: 1 2 3

Related biology news :

1. Leader in cancer treatment and prevention research honored
2. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
3. Chemical derived from vitamin-E shows early promise as cancer drug
4. New molecular link key to cellular proteins involved in cancer progression, other diseases
5. Phase II trials of second-generation antisense cancer drug planned following successful early study
6. Trial shows which brain cancer patients benefit from temozolomide
7. Genetic differences might help distinguish thyroid cancers
8. Evidence builds for potential new cancer drug target
9. New sequence involved in DNA replication timing may aid in cancer detection
10. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival
11. Cannabis may help combat cancer-causing herpes viruses

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2020)... ... ... Worldwide Business with kathy ireland® has announced an exclusive interview with ... and Marketing Jeff Maier to discuss their innovative technology, High-Speed Vibration Therapy. The segment ... at 5:30 p.m. EST and internationally on Bloomberg Television on Saturday, Jan. 25, 2020 ...
(Date:1/22/2020)... ... January 21, 2020 , ... ... lead the company’s new Business Development Department. The move, which is part of ... been previously serving as the company’s Senior Vice President where he oversaw its ...
(Date:1/8/2020)... ... January 08, 2020 , ... R3 Stem Cell, ... to its nationwide practice network partners. Not only does this save practices ... its Network the biologics themselves are less expensive. , Since the regenerative biologics ...
Breaking Biology News(10 mins):
(Date:1/22/2020)... ... January 20, 2020 , ... Brilliant, ... WAVE Electronics, the largest independent electronics distributor in the US, to make it ... Home Systems with leading smart home products from a single fulfillment partner. Ranging ...
(Date:1/22/2020)... FARMINGTON, Conn. (PRWEB) , ... January 21, 2020 , ... ... Cell (CTC) liquid biopsy from a simple blood draw, today announced the sale of ... UConn Health. The Rare Scope will be used in clinical cancer research. , “The ...
(Date:1/10/2020)... (PRWEB) , ... January 09, 2020 , ... ... China, today announced its inaugural GenScript Biotech Global Forum on Jan. 14 in ... the theme "Cell and Gene Therapy and the Booming China Market," will feature ...
(Date:1/7/2020)... ... January 07, 2020 , ... ... today announced the launch of its VivopureX™ recombinant mouse antibodies for in vivo ... obtained from rats or hamsters, which Absolute Antibody has engineered into mouse-anti-mouse recombinant ...
Breaking Biology Technology:
Cached News: